AI assistant
Sending…
AtriCure, Inc. — Director's Dealing 2019
Jul 3, 2019
31802_dirs_2019-07-02_aef65849-b5cf-46d7-810a-9ccd39a7bbb6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2019-06-30
Reporting Person: Privitera Salvatore (Chief Technology Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-06-30 | Common Stock | A | 717 | $25.36 | Acquired | 91627 | Direct |
Footnotes
F1: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2019.
F2: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 28, 2019, which was the last trading day of the applicable offering period. The closing price on June 28, 2019 was $29.84.
More from AtriCure, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 6
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3